Related Experiment Videos
Gene therapy for cerebrovascular disease
C Weihl1, R L Macdonald, M Stoodley
1Department of Neurology, University of Chicago Medical Center and Pritzker School of Medicine, Illinois 60037, USA.
Neurosurgery
|February 5, 1999
Summary
Gene therapy shows promise for cerebrovascular diseases, utilizing various vectors for gene transfer. This approach is rapidly advancing and expected to significantly impact neurosurgery soon.
Area of Science:
- Neurology
- Genetics
- Vascular Biology
Background:
- Cerebrovascular diseases represent a significant health burden.
- Current treatments have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the fundamental principles of gene therapy for cerebrovascular diseases.
- To summarize experimental and clinical findings related to gene therapy in this field.
Main Methods:
- Comprehensive literature review of gene therapy approaches for cerebrovascular conditions.
Main Results:
- Various vectors, including viral (adenovirus, retrovirus, AAV, herpes simplex virus) and non-viral (naked DNA, liposomes), are employed for gene transfer.
- Successful transfection and transgene expression achieved in cerebral vasculature and brain tissue via intra-arterial, perivascular, and intrathecal administration.
- Demonstrated biological effects include enhanced nitric oxide production, reduced neuronal damage in ischemia, and decreased blood pressure.
Conclusions:
- Gene therapy for cerebrovascular disease is nearing clinical application and poised to revolutionize neurosurgery.
- Neurosurgeons must stay informed about the evolving research and therapeutic potential of gene therapy.